BioSIM 抗人 SLAMF7/CS1 抗体 (阿妥昔珠单

BioSIM 抗人 SLAMF7/CS1 抗体 (阿妥昔珠单抗)

生物类似药 · 科研用途

产品背景

该BioSIM抗人SLAMF7/CS1抗体是一种高纯度的重组生物类似抗体，靶向SLAMF7/CS1蛋白。SLAMF7（信号淋巴细胞激活分子家族成员7），也称为CS1（骨髓瘤细胞表面标志物1），是自然杀伤细胞、部分T细胞和B细胞表面的重要免疫调节分子，同时也是多发性骨髓瘤细胞表面的特征性标志物。

生产特点

• 在无动物成分的生产设施中制造
• 采用无蛋白细胞培养技术
• 多步骤纯化工艺，包括Protein A或G色谱技术
• 确保抗体的特异性和高纯度

研究领域与应用

该抗体主要用于多发性骨髓瘤（MM）的研究领域，适用于以下实验类型：

• ELISA: 酶联免疫吸附测定，用于检测SLAMF7/CS1蛋白表达
• FACS: 流式细胞术，用于细胞表面SLAMF7/CS1的检测与分析
• Functional assay: 功能性实验，研究SLAMF7/CS1信号通路
• Research in vivo: 体内研究，探索多发性骨髓瘤的发病机制和治疗靶点

保存建议

为确保抗体活性和稳定性，请遵循以下保存条件：

• 避免反复冻融
• 短期保存（1-2周）：4°C
• 中期保存（最长12个月）：-20°C
• 长期保存：-80°C

免疫原性信息

该抗体的免疫原性详情请参考产品说明书。如有特殊应用场景下的免疫原性考量，建议在使用前咨询技术支持。

注意事项

本产品仅供研究使用，不适用于诊断或治疗目的。实验前请仔细阅读产品说明书，并根据具体实验需求优化实验条件。

注意：以上信息可能随着产品优化升级等因素产生变动，具体信息请咨询亚科因公司。

BioSIM anti-Human SLAMF7/CS1 Antibody (Azintuxizumab)

Biosimilar · Research Use Only

Product Background

This BioSIM anti-Human SLAMF7/CS1 Antibody is a highly purified recombinant biosimilar antibody targeting the SLAMF7/CS1 protein. SLAMF7 (Signaling Lymphocytic Activation Family Member 7), also known as CS1 (Cell Surface Marker 1), is an important immunoregulatory molecule on the surface of natural killer cells, certain T cells and B cells, and is also a characteristic marker on the surface of multiple myeloma cells.

Production Features

• Manufactured in animal component-free production facilities
• Uses protein-free cell culture technology
• Multi-step purification process including Protein A or G chromatography
• Ensures antibody specificity and high purity

Research Areas and Applications

This antibody is mainly used in the research field of multiple myeloma (MM) and is suitable for the following experimental types:

• ELISA: Enzyme-Linked Immunosorbent Assay for detecting SLAMF7/CS1 protein expression
• FACS: Flow Cytometry for detection and analysis of cell surface SLAMF7/CS1
• Functional assay: Functional experiments to study SLAMF7/CS1 signaling pathways
• Research in vivo: In vivo research to explore the pathogenesis and therapeutic targets of multiple myeloma

Storage Recommendations

To ensure antibody activity and stability, please follow the following storage conditions:

• Avoid repeated freeze-thaw cycles
• Short-term storage (1-2 weeks): 4°C
• Medium-term storage (up to 12 months): -20°C
• Long-term storage: -80°C

Immunogenicity Information

Please refer to the product manual for details on the immunogenicity of this antibody. For immunogenicity considerations in special applications, it is recommended to consult technical support before use.

Precautions

This product is for research use only and is not intended for diagnostic or therapeutic purposes. Please read the product manual carefully before experiments and optimize experimental conditions according to specific experimental needs.

Note: The above information may change due to factors such as product optimization and upgrading. For specific information, please consult Yakogen Corporation.